Skip to main content

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Opportunities

New Simplified Review Framework for NIH Research Project Grants

Alert For due dates on or after January 25, 2025 - changes to how most research grant applications will be reviewed. Learn about the new simplified review framework.

Alert For due dates after January 25, 2025 - changes are coming to the application and review of NIH fellowship applications. Learn about these changes.

Use the search box to narrow the list of funding opportunities. Be sure to also look for Notices of Special Interest (NOSIs) listed in Funding Notices.

NOTICE OF FUNDING OPPORTUNITY NOFO # Release date Expiration date
Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed) RFA-EB-25-002
Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed) RFA-NS-24-038
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-25-080
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) RFA-MH-26-120
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) RFA-NS-25-017
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) RFA-NS-25-018
Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-24-255
Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) RFA-OD-24-010
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253